reverse-phase HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-02-07. Numbers and descriptions here follow the published literature rather than marketing material.
Approved use is narrow and jurisdiction-specific. In the United States, the injectable product is authorised for premenopausal women with acquired, generalised hypoactive sexual desire disorder, a diagnosis that requires documented distress. It is not approved for men, for postmenopausal women, or for use alongside hormonal contraceptives under the approved labelling. Outside regulated markets, the same peptide is frequently sold as a research chemical, where identity, purity, and sterility are not independently verified.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
The compound emerged from a research programme examining melanocortin analogues for effects on skin pigmentation. During early human studies, participants reported spontaneous erections as an unexpected side effect, which redirected development toward sexual function rather than tanning. An intranasal formulation was investigated in clinical trials but did not reach market approval. A subcutaneous injectable version later completed the regulatory process, and the nasal route does not appear in approved labelling.
Reconstitution is usually performed with sterile water or a dilute acetic acid solution, and the choice of solvent affects both dissolution speed and final pH. Complete dissolution should be confirmed by visual inspection before any aliquot is taken, since undissolved particles can concentrate in the sampling volume. Repeated freeze-thaw cycles are the most common cause of gradual loss of purity, so dividing a stock into single-use aliquots at the first opportunity is standard practice. Working solutions kept refrigerated are generally used within days rather than weeks.
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
Lyophilized peptide arrives as a white to off-white cake or powder and is normally held at minus twenty degrees Celsius or colder for extended periods. Short-term bench work at ambient temperature is tolerable for minutes, not hours, because the solid is hygroscopic and picks up moisture that promotes hydrolysis. Vials should stay in a desiccator or a sealed bag with desiccant, protected from light, since aromatic residues in the sequence are susceptible to photo-oxidation. Inventory records that note arrival date and storage location reduce the chance of using degraded material.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Cyclic heptapeptide backbone |
| Molecular mass | Approximately 1025 Da | Nominal mass of the free peptide |
| Appearance | White to off-white lyophilised powder | Typical for purified synthetic peptides |
| Solubility class | Freely soluble in water | Organic solubility is limited |
| Typical storage temperature | −20 °C or below | Protect from moisture and light |
Certificate of analysis documents usually report purity percentage, molecular weight, and appearance. Researchers verify identity by comparing observed and theoretical mass values. Chain-of-custody records and batch numbers help trace material from source to experiment. Independent verification of supplier claims is considered good practice when material identity is critical to a study. Records should include the storage history of each aliquot, and unexpected deviations in appearance or solubility warrant re-testing before use.
Lyophilized peptide material is generally stored at -20 °C or below to limit degradation, while reconstituted solutions are less stable and are typically kept refrigerated and protected from light. Repeated freeze-thaw cycles can accelerate aggregation and should be minimized. Stability for any specific lot depends on purity, moisture content, and packaging. Handling in a temperature-controlled environment reduces variability across replicates, and exposure to ambient humidity during weighing can introduce error. Aliquotting reduces the number of times a stock container is opened.
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
Reported pharmacodynamic effects include transient rises in blood pressure and heart rate, flushing, nausea and headache, appearing soon after dosing and resolving within hours. These responses were dose-related in early studies and shaped the label's cardiovascular cautions and blood pressure monitoring advice. Gastrointestinal upset is the most frequent reason cited for discontinuation in trials. Whether the vascular signal attenuates with repeated use is not settled. Central effects on desire are described as emerging over weeks rather than immediately, which points to a cumulative rather than acute process.
The compound binds several melanocortin receptor subtypes rather than a single target, with the strongest functional activity reported at MC4R and measurable activity at MC1R, MC3R and MC5R. MC4R populations are dense in hypothalamic nuclei that integrate energy balance, autonomic tone and reproductive behaviour, which is the anatomical basis for the proposed pro-desire effect. Because binding is not subtype-selective, pigmentary and vascular effects accompany central activity. Improving subtype selectivity is an active area of analogue design. Direct causal mapping from receptor occupancy to reported desire change in humans is not fully established.
After subcutaneous dosing, peak plasma concentrations appear within roughly one hour, and elimination is fast, with a half-life on the order of a few hours. Degradation is mainly proteolytic, and at least one circulating fragment retains receptor activity, so parent-drug levels alone do not describe total exposure. Clearance does not depend heavily on hepatic cytochrome enzymes, which lowers the likelihood of common metabolic interaction routes. Data in renal or hepatic impairment are limited. Repeated dosing does not appear to produce marked accumulation given the short half-life.
The peptide contains seven amino acids arranged in a ring, closed by a lactam bridge between a side-chain acid and an amine. This cyclic constraint holds the backbone in a defined conformation and increases resistance to enzymatic breakdown relative to linear analogs. N-terminal acetylation and a C-terminal amide further protect the molecule from exopeptidases. The result is a compound with a comparatively long circulation time for a small peptide. Structural modification of the bridge alters receptor affinity, which is one reason analogs in this family differ in their subtype preferences.
Whether the behavioral effect originates centrally, peripherally, or through both remains an active question. Animal experiments using receptor antagonists and site-specific injections point toward hypothalamic melanocortin circuits as a key locus, but translating those findings to humans is not straightforward. Blood pressure changes observed in trials suggest a vascular component that may be peripherally mediated. The relationship between receptor occupancy and reported effect has not been mapped in humans, and no validated biomarker predicts response. This gap makes it difficult to explain individual variability on pharmacological grounds alone.
Bremelanotide acts as an agonist at melanocortin receptors, a family of five G-protein-coupled receptors labeled MC1 through MC5. Binding studies indicate activity at several of these subtypes rather than strict selectivity for one. Signalling proceeds mainly through Gs-mediated activation of adenylyl cyclase, raising intracellular cyclic AMP. The MC4 receptor, expressed in hypothalamic and limbic circuits, is widely regarded as the subtype most relevant to sexual response. Because the molecule is not subtype-selective, effects at other melanocortin receptors are expected and are used to explain some observed side effects.
=== Cell layers === Transitional epithelium is made up of three types of cell layers: basal, intermediate, and superficial. The basal layer fosters the epithelial stem cells in order to provide constant renewal of the epithelium, and each basal cell contacts the basement membrane. These cells' cytoplasm is rich in tonofilaments and mitochondria; however, they contain few rough endoplasmic reticulum. The tonofilaments play a role in the attachment of the basal layer to the basement membrane via desmosomes. The intermediate cell layer is highly proliferative and, therefore, provides for rapid cell regeneration in response to injury or infection of the organ or tube in which it resides. These cells contain a prominent Golgi apparatus and an array of membrane-bound vesicles. These function in the packaging and transport of proteins, such as keratin, to the superficial cell layer. The cells of the superficial cell layer that lines the lumen are known as facet cells or umbrella cells. This layer is the only fully differentiated layer of the epithelium. It provides an impenetrable barrier between the lumen and the bloodstream, so as not to allow the bloodstream to reabsorb harmful wastes or pathogens. All transitional epithelial cells are covered in microvilli and a fibrillar mucous coat. The epithelium contains many intimate and delicate connections to neural and connective tissue. These connections allow for communication to tell the cells to expand or contract.
== History == The study of lichen acids related to protolichesterinic acid began in 1845, when Schnedermann and Wilhelm Knop isolated lichesterinic acid from Cetraria islandica var. vulgaris. They determined it had a melting point around 120 °C (248 °F) and established its composition as C19H32O4. Further research by H. Sinnhold in 1898 worked with pure lichesterinic acid (melting point 124.5–125 °C). In 1900, Oswald Hesse isolated three varieties (α-, β-, and γ-) of lichesterinic acid from Cetraria islandica, with specific rotations of +27.9°, +27.9°, and +16° respectively. Protolichesterinic acid was first isolated at the beginning of the 20th century by Friedrich Wilhelm Zopf from the lichen Cetraria cucullata (now known as Cladocetraria cucullata). Zopf initially found it alongside usnic acid and noticed that while it showed similarities to lichesterinic acid in some properties, it differed significantly in melting point and other characteristics. The compound was named "protolichesterinic acid" to reflect its close relationship to lichesterinic acid, and the discovery was published in Liebigs Annalen in 1902. After obtaining it in crystalline form through extraction with ether and recrystallization from warm benzol, Zopf determined that protolichesterinic acid formed thin, rhombic, pearly plates that melted at 103–104 °C (217–219 °F), lower than lichesterinic acid's melting point of 124–125 °C (255–257 °F).
The Grand Lodge, being only responsible for the first three degrees, does not represent all of Cuban Freemasonry without the Supreme Council, which is responsible for all the higher degrees, from the 4th to the 33rd degrees. Cuban Freemasons considered this as an insult to the Supreme Council, and an attempt to reject the Grand Commander's authority. Cuban Freemasons sent a flood of calls, emails, and letters to the office of Grand Master Zamora Fernández to refuse to meet with the President. On August 23, Zamora Fernández wrote a letter distributed to Cuban Freemasons indicating that the office of the Grand Master had decided not to attend the meeting "...in order to preserve Masonic unity". The Freemason and Cuban activist writer Ángel Santiesteban Prats stated that President Díaz-Canel's full intention was to completely fracture Freemasonry in Cuba. Santiesteban said: "I doth my hat to the Grand Master's wise decision. Masonic unity above all. History is being made... it is a milestone in our country's history, especially over the last 62 years. I remind you that Freemasonry is the only institution in Cuba that didn't dance like puppets on the stage with Fidel Castro and demand the return of that boy Elián. Everybody else gave in. The Abakuás, the spiritists, and the Yoruba Association, they all caved to Castro." On March 28, 2022, Grand Treasurer Francisco Javier Alfonso Vidal was elected as Grand Master of the Grand Lodge of Cuba.
=== Anti-inflammatory uses === One of its therapeutic effects is its ability to reduce inflammatory responses by decreasing synthesis of pro-inflammatory cytokines and inhibiting inflammatory signaling pathways, such as NF-kB. Excessive inflammation not only further damages tissue but also slows the healing process, making PDRN's anti-inflammatory activity as a key feature of its effects. PDRN showed modulation of markers connected to chronic low-grade inflammation (also referred to as inflammaging) and age-related deterioration, suggesting these properties may enhance tissue homeostasis under conditions of prologed stress.
Sources: en.wikipedia.org
=== May === 1 May – Bob Brockie, biologist, cartoonist (National Business Review) and columnist (Dominion Post) (born 1932). 2 May – Sir Bob Jones, property magnate, writer, and politician, founder of the New Zealand Party (1983) (born 1939). 5 May Shane Richardson, motorcycle racer (born c. 1996). Shane Solomon, lawyer and Māori leader (Waikato Tainui) (born 1963). 6 May – Bill McCaw, rugby union player (Southland, national team), oldest living All Black (since 2023) (born 1927). 9 May – Fred Graham, rugby union player (New Zealand Māori), educator and sculptor, Te Tohu mō Te Arikinui Dame Te Atairangikaahu (2017), Arts Foundation of New Zealand Icon (since 2018) (born 1928). 13 May – Danny Lendich, businessman and midget car racing team owner, introduced Wendy's to New Zealand (1988) (born 1944). 14 May – Lionel Hill-Smith, Empire Games hurdler (1950) (born 1929). 15 May – Durham Havill, local politician and businessman, Mayor of Westland (1989–1998) (born 1944). 16 May – Tuppy Diack, rugby union player (Otago, Southland, national team) and administrator, president of the Otago Rugby Football Union (2005) (born 1930). 17 May – Clive Rennie, educator, principal of Rangitikei College (1986–1991), Mountainview High School (1997–2000) and Otago Boys' High School (2000–2014) (born 1944). 18 May – John Simpson, silversmith and fine arts academic (University of Canterbury) (born 1925). 21 May – Frank Gibson Jr., jazz drummer and drum tutor (born 1946). 23 May – Roger Bridge, businessman and political party official (National) (born 1958).
G-protein-coupled receptor (GPCR) A large family of membrane receptors that activate intracellular signaling pathways through G-proteins. GPCRs are critical in neurotransmission, hormone signaling, and sensory perception. Granule cell A small neuron found in the cerebellum, olfactory bulb, and dentate gyrus of the hippocampus. Granule cells play important roles in sensory and motor information processing. Granulomatosis with polyangiitis An autoimmune disease that can affect the central nervous system, sometimes causing neuropathy, headaches, or stroke-like symptoms due to vascular inflammation. Grasp reflex A primitive reflex seen in infants where touching the palm induces the hand to close. Persistence in adults may indicate frontal lobe damage. Gray matter Brain tissue composed primarily of neuronal cell bodies, dendrites, and unmyelinated axons. It is responsible for information processing and synaptic transmission. Growth cone A dynamic, motile structure at the tip of a developing axon or dendrite that guides neuronal growth by sensing molecular cues in the environment. Growth factor A naturally occurring protein that stimulates cell growth, differentiation, and survival. Examples include BDNF, NGF, and EGF in neural development and repair. Gustatory cortex The brain area responsible for processing taste information, primarily located in the insular and frontal opercular regions. Gyri (singular gyrus) The raised ridges or folds of the cerebral cortex. They increase the brain’s surface area and are separated by sulci (grooves).
81.9% of voters decided for Baden to remain part of Baden-Württemberg, only 18.1% opted for the reconstitution of the old state of Baden. The referendums in Lower Saxony and Rhineland-Palatinate were held on 19 January 1975 (the percentages given are the percentages of those eligible who voted in favour):
== Classification == Kwashiorkor is a type of severe acute malnutrition (SAM). SAM is a category, composed of two conditions: marasmus and kwashiorkor. Both kwashiorkor and marasmus fall under the umbrella of protein–energy malnutrition (PEM). These diseases are oftentimes discussed together, but are distinctly separate conditions of malnutrition. Kwashiorkor is marked by an array of metabolic disturbances of uncertain cause. In contrast, marasmus is more clearly an energy deficiency syndrome, marked by weight loss. On physical exam, kwashiorkor is also distinguished from marasmus by the presence of edema. When children present with both kwashiorkor and marasmus, the condition is referred to as "marasmic-kwashiorkor". In general, kwashiorkor is marked by more profound serum depletions of antioxidant molecules and minerals, relative to marasmus.
In the United States, the Food and Drug Administration (FDA) is responsible for creating guidelines for the approval and use of drugs. The FDA requires that all approved drugs fulfill two requirements:
Sources: en.wikipedia.org
== Adverse effects == Adverse effects of teicoplanin are usually limited to local effects or hypersensitivity reactions. While there is potential for nephrotoxicity and ototoxicity, the incidence of such organ toxicity is rare if recommended serum concentrations are successfully maintained.
Collagen alpha-1(IX) chain is a protein that in humans is encoded by the COL9A1 gene. This gene encodes one of the three alpha chains of type IX collagen, a collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene may be associated with multiple epiphyseal dysplasia. Two transcript variants have been identified for this gene.
In 2024, Andrea Cau published a study on the phylogenetics of compsognathids that called the assessment of these taxa into question. The paper recovered Sinosauropteryx, along with three other proposed compsognathids in a polytomy within basal Coelurosauria. This polytomy notably did not include Composognathus proper, which would make none of these species compsognathids. In their description of S. lingyuanensis, Qiu et al. (2025) also commented on the monophyly of Compsognathidae and revived the previously monotypic Sinosauropterygidae within Coelurosauria as a monophyletic family containing all compsognathid-like theropods from the Jehol Biota of China (Sinosauropteryx, Huadanosaurus, Huaxiagnathus and Sinocalliopteryx) in addition to Mirischia. Their phylogenetic analyses using two separate datasets are reproduced below:
== Iron-57 == 57Fe is widely used in Mössbauer spectroscopy and the related nuclear resonance vibrational spectroscopy due to the low natural variation in energy of the 14.4 keV nuclear transition. The transition was famously used to make the first definitive measurement of gravitational redshift, in the 1960 Pound–Rebka experiment.
== Nutrition == Dried chia seeds contain 6% water, 42% carbohydrates (including a high content of dietary fiber), 16% protein, and 31% fat (table). In a reference amount of 100 grams (3.5 oz), chia seeds supply 486 calories and are a rich source (20% or more of the Daily Value, DV) of the B vitamins, thiamin and niacin (52% and 55% DV, respectively). They are also a moderate source of riboflavin (13% DV) and folate (12% DV). The seeds contain dense amounts of several dietary minerals, including calcium, iron, magnesium, manganese, phosphorus, and zinc (all more than 20% DV; table). Chia oil contains a high percentage of essential fatty acids (approximately 60%) and a low content of saturated fatty acids. The fats of chia seed oil are mainly unsaturated, with linoleic acid (17–26% of total fat) and α-linolenic acid (50–57%) as the major fatty acids (see table).
Sources: en.wikipedia.org
It is a synthetic cyclic peptide that acts as an agonist at melanocortin receptors. It is not a hormone replacement therapy and not a vasodilator in the usual clinical sense, although it does affect vascular tone. Chemically it belongs to the melanocortin analogue family.
PT-141 was the internal development code used during early research and it persists in older publications, conference abstracts, and informal listings. The code and the approved name refer to the same molecule. Its continued use reflects habit in the literature rather than any difference in substance.
No. The intranasal form was studied in trials but was never approved, and absorption through the nasal route varies considerably between individuals. Approved labelling covers a subcutaneous injection only. Any nasal product sold outside regulated channels falls outside verified manufacturing.
Cold storage at minus twenty degrees Celsius or below is typical, with desiccant and protection from light. The solid form is far more stable than any solution.